Project Grant R34AA032821
Award Date 8/15/26
Completion Date 7/31/29
Dollars Obligated $719K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Houston, TX 77030, USA
Similar Awards
- The National Institute on Alcohol Abuse and Alcoholism awarded Brown University $628,846 on September 25, 2025, under the Alcohol Research Programs (CFDA 93.273) to develop and evaluate virtual reality interventions that immerse patients with alcohol use disorder in realistic high-risk situations to help them identify triggers, experiment with coping strategies, and practice deploying those strategies in simulated environments. The project addresses a treatment gap: only about one-third of...
- The National Institute on Alcohol Abuse and Alcoholism awarded Yale University $576,197 on September 16, 2025, under the Alcohol Research Programs (CFDA 93.273) to develop and test a digital pill system paired with smartphone-delivered cognitive behavioral therapy to measure and support acamprosate adherence in individuals with alcohol use disorder and alcohol-associated liver disease. Yale will develop a user-centered adherence intervention called ACAMPROSYNC that combines a digital pill system...
- The National Institute on Alcohol Abuse and Alcoholism awarded Texas A&M University System Health Science Center $635,002 on June 15, 2026, under the Alcohol Research Programs (CFDA 93.273) to investigate cholinergic modulation of striatal circuits in alcohol use disorder. The project examines how chronic alcohol intake affects acetylcholine signaling in the dorsomedial striatum, focusing on the interaction between direct-pathway medium spiny neurons and cholinergic interneurons. Research...
- The National Institute on Alcohol Abuse and Alcoholism awarded Real Recovery VR, Inc. $928,356 on September 15, 2025, to develop a virtual reality platform that counselors can use to enhance treatment techniques and improve outcomes among those with alcohol use disorder under the Alcohol Research Programs (CFDA 93.273). The VR platform will enable counselors to provide immersive, simulation-based training in coping skills that patients can practice in high-risk scenarios without relying...
- The National Institute on Alcohol Abuse and Alcoholism awarded Yale University $182,183 on September 1, 2026, under the Alcohol Research Programs (CFDA 93.273) to develop artificial intelligence agents that generate personalized, multimedia cognitive behavioral therapy content for alcohol use disorder treatment, targeting English speakers and Spanish speakers. The project will create AI-generated CBT content delivered via smartphone to address high-risk drinking periods, such as weekends. The...
- The National Institute on Alcohol Abuse and Alcoholism awarded the University of Houston System $706,832 on August 10, 2026, under the Alcohol Research Programs grant program (CFDA 93.273) to develop and evaluate a personalized digital intervention addressing hazardous alcohol use and negative affect among people with HIV. The intervention, called I-PFI (Integrated Personalized Feedback Intervention), is a single-session, computer-delivered program lasting 20–30 minutes that provides...
- The National Institute on Alcohol Abuse and Alcoholism awarded Washington State University $498,203 under the Alcohol Research Programs (CFDA 93.273) on August 1, 2026, to develop a just-in-time adaptive music-listening mobile health intervention for stress reduction among individuals in early recovery from alcohol use disorder. The research aims to create the first music-listening intervention leveraging passive sensing and machine learning to automatically predict and respond to moments of...
- The National Institute on Alcohol Abuse and Alcoholism awarded the University of Texas at Arlington $596,443 on September 1, 2026, under the Alcohol Research Programs (CFDA 93.273) to conduct a randomized controlled trial examining the effect of alcohol abstinence on cardiovascular disease risk factors. The research will enroll men and women who drink above recommended limits but are free of alcohol use disorder and cardiovascular disease. The study employs a novel alcohol abstinence...
- The National Institute on Alcohol Abuse and Alcoholism awarded Trustees of Boston University $580,556 on May 1, 2026, under the Alcohol Research Programs (CFDA 93.273) to investigate the role of pituitary adenylate cyclase activating polypeptide (PACAP) in heavy alcohol drinking and associated anxiety-like behavior. The recipient will conduct mechanistic research using animal models of heavy alcohol drinking combined with pharmacological, molecular, and viral approaches to test whether the...
- The National Institute on Alcohol Abuse and Alcoholism awarded the University of Rhode Island $1,403,716 on September 20, 2025, under the Alcohol Research Programs (CFDA 93.273) to examine transactional relationships between sensor-derived alcohol use data and acute suicide risk during community re-entry following residential alcohol use disorder treatment. The research uses ecological momentary assessment and transdermal alcohol sensor technology (BACtrack Skyn) to assess time-varying,...